The DCB therefore began work on its BioFronts project a year and a half ago. BioFronts gathers and evaluates research from both Taiwan and abroad. Based on these evaluations, BioFronts assembles strategic alliances that import the technologies necessary to develop mid-stream production processes and acquire the Asian rights to these technologies.
在這種考量下，生技中心從一年半前推出 BioFronts 方案，在國內外廣蒐資訊，經過評鑑後訂定策略聯盟，再引進國內進行中游產程的開發，並藉此取得亞洲市場的經營權和生產權。